A Blueprint for Enhancing the Security of the Pharmaceutical Supply Chain

A closely connected, diverse and resilient pharmaceutical supply chain based in the United States and in U.S. allied countries (for example, Canada, Europe, India, Israel and Jordan) is the best means to ensure that U.S. patients and the U.S. health care system have access to a secure and consistent supply of critical pharmaceuticals.The United States already plays an important role in this supply chain, with generic companies providing more than 36,000 jobs at nearly 150 facilities, and manufacturing more than 61 billion doses of prescription medicines annually.

With strategic support from the U.S. government, the economic footprint of the generic drug industry in the U.S. can expand even more, leading to increased national security, a reduction of dependence on any one country for key pharmaceuticals or their components and an expanded employment base.

To view the original report, please click here